These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27774793)

  • 1. Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?
    Fathi S; Oyelere AK
    Future Med Chem; 2016 Nov; 8(17):2091-2112. PubMed ID: 27774793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal drug delivery systems: an update review.
    Samad A; Sultana Y; Aqil M
    Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
    Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
    Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding and interstitial penetration of liposomes within avascular tumor spheroids.
    Kostarelos K; Emfietzoglou D; Papakostas A; Yang WH; Ballangrud A; Sgouros G
    Int J Cancer; 2004 Nov; 112(4):713-21. PubMed ID: 15382056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of liposomal formulations for cell targeting.
    Nogueira E; Gomes AC; Preto A; Cavaco-Paulo A
    Colloids Surf B Biointerfaces; 2015 Dec; 136():514-26. PubMed ID: 26454541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous liposome membranes with pH-triggered permeability enhance the in vitro antitumor activity of folate-receptor targeted liposomal doxorubicin.
    Mamasheva E; O'Donnell C; Bandekar A; Sofou S
    Mol Pharm; 2011 Dec; 8(6):2224-32. PubMed ID: 21899300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes as biocompatible and smart delivery systems - the current state.
    Dymek M; Sikora E
    Adv Colloid Interface Sci; 2022 Nov; 309():102757. PubMed ID: 36152374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines.
    Caracciolo G
    Nanomedicine; 2015 Apr; 11(3):543-57. PubMed ID: 25555353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
    Wang F; Chen L; Zhang R; Chen Z; Zhu L
    J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the Application of Liposomes as Drug Delivery Systems for the Diagnosis and Treatment of Cancer.
    Allahou LW; Madani SY; Seifalian A
    Int J Biomater; 2021; 2021():3041969. PubMed ID: 34512761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery.
    Eloy JO; Claro de Souza M; Petrilli R; Barcellos JP; Lee RJ; Marchetti JM
    Colloids Surf B Biointerfaces; 2014 Nov; 123():345-63. PubMed ID: 25280609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal Drug Delivery and Its Potential Impact on Cancer Research.
    Bhattacharya S; Saindane D; Prajapati BG
    Anticancer Agents Med Chem; 2022 Aug; 22(15):2671-2683. PubMed ID: 35440318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-targeted liposome design: challenges and fundamental considerations.
    Noble GT; Stefanick JF; Ashley JD; Kiziltepe T; Bilgicer B
    Trends Biotechnol; 2014 Jan; 32(1):32-45. PubMed ID: 24210498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted liposomal drug delivery in cancer.
    Medina OP; Zhu Y; Kairemo K
    Curr Pharm Des; 2004; 10(24):2981-9. PubMed ID: 15379663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends and developments in liposome drug delivery systems.
    Lian T; Ho RJ
    J Pharm Sci; 2001 Jun; 90(6):667-80. PubMed ID: 11357170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal Nanotechnology for Cancer Theranostics.
    Yue X; Dai Z
    Curr Med Chem; 2018; 25(12):1397-1408. PubMed ID: 28266269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona.
    Caracciolo G
    Nanoscale; 2018 Mar; 10(9):4167-4172. PubMed ID: 29450412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes in the Targeted Gene Therapy of Cancer: A Critical Review.
    Akkewar A; Mahajan N; Kharwade R; Gangane P
    Curr Drug Deliv; 2023; 20(4):350-370. PubMed ID: 35593362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation.
    Nallamothu R; Wood GC; Pattillo CB; Scott RC; Kiani MF; Moore BM; Thoma LA
    AAPS PharmSciTech; 2006 Apr; 7(2):E32. PubMed ID: 16796350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.